Owkin, a French-American biotechnology company that uses artificial intelligence (AI) in drug discovery and development as well as diagnostics, announced a collaboration agreement with MSD, the trade name of Merck & Co Inc, to develop and...
Gilead Sciences, Inc has announced an exclusive license deal with Compugen Ltd. to license its potential first-in-class, pre-clinical antibody program against IL-18 binding protein, which includes the COM503 drug candidate. Compugen Ltd. is a...
Chugai Pharmaceutical Co., Ltd. announced its plan to invest in their Bio drug substance (DS) manufacturing facility "UK3" at Chugai Pharma Manufacturing Co., Ltd.'s Ukima Plant (Kita-ku, Tokyo). UK3 includes DS production for phase 3 clinical...
The Oral Health Collaborative recently formed the 'National Oral Health Task Force', a critical step in improving the oral health landscape in India. Taru Leading Edge, a New Delhi-based think tank, arranged the event, which was sponsored by...
Knight Therapeutics Inc announced an exclusive license agreement with Supernus Pharmaceuticals Inc, a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, granting...
As per LEO Pharma Inc, Adbry (tralokinumab-ldrm) is now approved for use in pediatric patients with moderate-to-severe atopic dermatitis (AD) aged 12 to 17 years. This approval extends to patients whose disease is not adequately controlled with...
Vijaya Diagnostic Centre Ltd announced that it will totally purchase Pune-based PH Diagnostic Centre Pvt Ltd for Rs 134.65 crore in cash. The board of directors of Vijaya Diagnostic Centre met on Tuesday and considered and approved the terms and...
JB Chemicals & Pharmaceuticals Ltd has signed a trade mark licence deal, as well as a promotion and distribution agreement, with Novartis for select ophthalmic brands worth Rs 1,089 crore. The board of directors approved the execution of a...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a global biotech company focused on the discovery and development of novel antibody therapeutics, has announced an antibody evaluation, option, and license agreement with Ona Therapeutics, a Spanish...
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, announced the approval of its New Drug Application (NDA) for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin...
, CDSCO.jpg)
.jpg)